The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo

Dmitriy N. Atochin, Annie Wang, Victor W T Liu, Jeffrey D. Critchlow, Ana Paula V Dantas, Robin Looft-Wilson, Takahisa Murata, Salvatore Salomone, Kyoung Shin Hwa, Cenk Ayata, Michael A. Moskowitz, Thomas Michel, William C. Sessa, Paul L. Huang

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

NO plays critical roles in vascular function. We show that modulation of the eNOS serine 1179 (S1179) phosphorylation site affects vascular reactivity and determines stroke size in vivo. Transgenic mice expressing only a phosphomimetic (S1179D) form of eNOS show greater vascular reactivity, develop less severe strokes, and have improved cerebral blood flow in a middle cerebral artery occlusion model than mice expressing an unphosphorylatable (S1179A) form. These results provide a molecular mechanism by which multiple diverse cardiovascular risks, such as diabetes and obesity, may be centrally integrated by eNOS phosphorylation in vivo to influence blood flow and cardiovascular disease. They also demonstrate the in vivo relevance of posttranslational modification of eNOS in vascular function.

Original languageEnglish
Pages (from-to)1961-1967
Number of pages7
JournalJournal of Clinical Investigation
Volume117
Issue number7
DOIs
Publication statusPublished - 2 Jul 2007
Externally publishedYes

Fingerprint

Brain Ischemia
Blood Vessels
Phosphorylation
Cerebrovascular Circulation
Stroke
Hematologic Diseases
Middle Cerebral Artery Infarction
Post Translational Protein Processing
Serine
Transgenic Mice
Cardiovascular Diseases
Obesity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Atochin, D. N., Wang, A., Liu, V. W. T., Critchlow, J. D., Dantas, A. P. V., Looft-Wilson, R., ... Huang, P. L. (2007). The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. Journal of Clinical Investigation, 117(7), 1961-1967. https://doi.org/10.1172/JCI29877

The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. / Atochin, Dmitriy N.; Wang, Annie; Liu, Victor W T; Critchlow, Jeffrey D.; Dantas, Ana Paula V; Looft-Wilson, Robin; Murata, Takahisa; Salomone, Salvatore; Hwa, Kyoung Shin; Ayata, Cenk; Moskowitz, Michael A.; Michel, Thomas; Sessa, William C.; Huang, Paul L.

In: Journal of Clinical Investigation, Vol. 117, No. 7, 02.07.2007, p. 1961-1967.

Research output: Contribution to journalArticle

Atochin, DN, Wang, A, Liu, VWT, Critchlow, JD, Dantas, APV, Looft-Wilson, R, Murata, T, Salomone, S, Hwa, KS, Ayata, C, Moskowitz, MA, Michel, T, Sessa, WC & Huang, PL 2007, 'The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo', Journal of Clinical Investigation, vol. 117, no. 7, pp. 1961-1967. https://doi.org/10.1172/JCI29877
Atochin, Dmitriy N. ; Wang, Annie ; Liu, Victor W T ; Critchlow, Jeffrey D. ; Dantas, Ana Paula V ; Looft-Wilson, Robin ; Murata, Takahisa ; Salomone, Salvatore ; Hwa, Kyoung Shin ; Ayata, Cenk ; Moskowitz, Michael A. ; Michel, Thomas ; Sessa, William C. ; Huang, Paul L. / The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. In: Journal of Clinical Investigation. 2007 ; Vol. 117, No. 7. pp. 1961-1967.
@article{a591b13470b046a38e7b6a367b8c7664,
title = "The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo",
abstract = "NO plays critical roles in vascular function. We show that modulation of the eNOS serine 1179 (S1179) phosphorylation site affects vascular reactivity and determines stroke size in vivo. Transgenic mice expressing only a phosphomimetic (S1179D) form of eNOS show greater vascular reactivity, develop less severe strokes, and have improved cerebral blood flow in a middle cerebral artery occlusion model than mice expressing an unphosphorylatable (S1179A) form. These results provide a molecular mechanism by which multiple diverse cardiovascular risks, such as diabetes and obesity, may be centrally integrated by eNOS phosphorylation in vivo to influence blood flow and cardiovascular disease. They also demonstrate the in vivo relevance of posttranslational modification of eNOS in vascular function.",
author = "Atochin, {Dmitriy N.} and Annie Wang and Liu, {Victor W T} and Critchlow, {Jeffrey D.} and Dantas, {Ana Paula V} and Robin Looft-Wilson and Takahisa Murata and Salvatore Salomone and Hwa, {Kyoung Shin} and Cenk Ayata and Moskowitz, {Michael A.} and Thomas Michel and Sessa, {William C.} and Huang, {Paul L.}",
year = "2007",
month = "7",
day = "2",
doi = "10.1172/JCI29877",
language = "English",
volume = "117",
pages = "1961--1967",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "7",

}

TY - JOUR

T1 - The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo

AU - Atochin, Dmitriy N.

AU - Wang, Annie

AU - Liu, Victor W T

AU - Critchlow, Jeffrey D.

AU - Dantas, Ana Paula V

AU - Looft-Wilson, Robin

AU - Murata, Takahisa

AU - Salomone, Salvatore

AU - Hwa, Kyoung Shin

AU - Ayata, Cenk

AU - Moskowitz, Michael A.

AU - Michel, Thomas

AU - Sessa, William C.

AU - Huang, Paul L.

PY - 2007/7/2

Y1 - 2007/7/2

N2 - NO plays critical roles in vascular function. We show that modulation of the eNOS serine 1179 (S1179) phosphorylation site affects vascular reactivity and determines stroke size in vivo. Transgenic mice expressing only a phosphomimetic (S1179D) form of eNOS show greater vascular reactivity, develop less severe strokes, and have improved cerebral blood flow in a middle cerebral artery occlusion model than mice expressing an unphosphorylatable (S1179A) form. These results provide a molecular mechanism by which multiple diverse cardiovascular risks, such as diabetes and obesity, may be centrally integrated by eNOS phosphorylation in vivo to influence blood flow and cardiovascular disease. They also demonstrate the in vivo relevance of posttranslational modification of eNOS in vascular function.

AB - NO plays critical roles in vascular function. We show that modulation of the eNOS serine 1179 (S1179) phosphorylation site affects vascular reactivity and determines stroke size in vivo. Transgenic mice expressing only a phosphomimetic (S1179D) form of eNOS show greater vascular reactivity, develop less severe strokes, and have improved cerebral blood flow in a middle cerebral artery occlusion model than mice expressing an unphosphorylatable (S1179A) form. These results provide a molecular mechanism by which multiple diverse cardiovascular risks, such as diabetes and obesity, may be centrally integrated by eNOS phosphorylation in vivo to influence blood flow and cardiovascular disease. They also demonstrate the in vivo relevance of posttranslational modification of eNOS in vascular function.

UR - http://www.scopus.com/inward/record.url?scp=34447116875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447116875&partnerID=8YFLogxK

U2 - 10.1172/JCI29877

DO - 10.1172/JCI29877

M3 - Article

VL - 117

SP - 1961

EP - 1967

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 7

ER -